The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)-1H-indole-3-carboxamide
ID: ALA1077587
Cas Number: 61788-27-0
PubChem CID: 12375091
Product Number: N726750, Order Now?
Max Phase: Preclinical
Molecular Formula: C15H11ClN2O
Molecular Weight: 270.72
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1c[nH]c2ccccc12
Standard InChI: InChI=1S/C15H11ClN2O/c16-12-6-2-4-8-14(12)18-15(19)11-9-17-13-7-3-1-5-10(11)13/h1-9,17H,(H,18,19)
Standard InChI Key: OYUBLAUHKNUTEB-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
14.8966 -0.3248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8954 -1.1515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6098 -1.5641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6079 0.0877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3228 -0.3211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3277 -1.1470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1146 -1.3976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5962 -0.7266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1067 -0.0614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1238 0.7611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8451 1.1603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4174 1.1863 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4324 2.0105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1584 2.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1737 3.2299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4691 3.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7431 3.2522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7313 2.4300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0112 2.0286 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 1 0
4 1 1 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 1 0
12 13 1 0
3 6 2 0
13 14 2 0
1 2 2 0
14 15 1 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.72 | Molecular Weight (Monoisotopic): 270.0560 | AlogP: 4.07 | #Rotatable Bonds: 2 |
Polar Surface Area: 44.89 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.78 | CX Basic pKa: ┄ | CX LogP: 3.77 | CX LogD: 3.77 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.72 | Np Likeness Score: -1.46 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |